Mark C. McKenna
Director · Apogee Therapeutics, Inc.
IndividualBuying only
- 2024
- Sep 3, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark C. McKenna files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $133.53M in APGE purchases and sales in the last 12 months
- Michael Thomas Henderson - $26.88M in APGE purchases and sales in the last 12 months
- Carl Dambkowski - $8.50M in APGE purchases and sales in the last 12 months
- Jane Henderson - $1.36M in APGE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark C. McKenna?
Mark C. McKenna is a corporate insider, tracked as Director of Apogee Therapeutics, Inc. (APGE). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark C. McKenna submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Mark C. McKenna been buying or selling stock?
Recorded transactions: 2 open-market purchases ($991K) and 0 open-market sales across all tracked filings.
